Showing results (391-400 of 2,398) with videos related to
Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|March 13, 2020
Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstructionYayoi Adachi, Seiko Okumura, Masataka Sawaki, et al.Breast Cancer (Tokyo, Japan)|March 13, 2020
Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysisSadaf Zehra, F Doyle, M Barry, et al.Breast Cancer (Tokyo, Japan)|February 3, 2020
Could ductoscopy alleviate the need of microdochectomy in pathological nipple discharge?Yuk-Kwan Chang, Clement Tzu-Hsin Chen, Min Wang, et al.Breast Cancer (Tokyo, Japan)|January 25, 2020
Risks and benefits of bevacizumab combined with chemotherapy for advanced or metastatic breast cancer: a meta-analysis of randomized controlled trialsMinoru Miyashita, Masaya Hattori, Toshimi Takano, et al.Breast Cancer (Tokyo, Japan)|September 18, 2020
Prospective observational study of chemotherapy-induced alopecia after sequential FEC + taxane and the effects of age in breast cancer patientsTakaaki Fujii, Kei Ichiba, Chikako Honda, et al.Breast Cancer (Tokyo, Japan)|January 3, 2021
Sentinel lymph node biopsy after introducing Twirl® breast markers into suspicious lymph nodes in breast cancer patientsTomohiro Miyake, Masafumi Shimoda, Tomonori Tanei, et al.Breast Cancer (Tokyo, Japan)|November 25, 2020
Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviewsXueyao Wu, Xiaofan Zhang, Yu Hao, et al.Breast Cancer (Tokyo, Japan)|January 2, 2021
Optimal duration of endocrine therapy with extended aromatase inhibitors for postmenopausal patients with hormone receptor-positive breast cancer: a meta-analysisJuan Chen, Xiaohui Zhang, Yan Lu, et al.Breast Cancer (Tokyo, Japan)|January 2, 2021
Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysisHaiyun Wang, Shijia Zhang, Douglas Yee, et al.Breast Cancer (Tokyo, Japan)|January 3, 2021
Relationship between MRI findings and invasive breast cancer with podoplanin-positive cancer-associated fibroblastsKen Yamaguchi, Yukiko Hara, Isao Kitano, et al.Pageof 240